Traders bought shares of Cardinal Health, Inc. (NYSE:CAH) on weakness during trading hours on Monday. $41.80 million flowed into the stock on the tick-up and $23.94 million flowed out of the stock on the tick-down, for a money net flow of $17.86 million into the stock. Of all companies tracked, Cardinal Health had the 21st highest net in-flow for the day. Cardinal Health traded down ($0.22) for the day and closed at $66.76

CAH has been the subject of several analyst reports. Zacks Investment Research downgraded Cardinal Health from a “hold” rating to a “sell” rating in a research note on Friday, April 28th. Credit Suisse Group reaffirmed a “buy” rating and set a $81.00 price objective on shares of Cardinal Health in a research note on Tuesday, May 2nd. William Blair downgraded Cardinal Health from an “outperform” rating to a “market perform” rating in a research note on Wednesday, April 19th. Tigress Financial initiated coverage on Cardinal Health in a research note on Friday, April 28th. They set a “neutral” rating for the company. Finally, Jefferies Group LLC initiated coverage on Cardinal Health in a research note on Wednesday, May 17th. They set a “hold” rating and a $77.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and four have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $80.46.

The stock has a market capitalization of $21.10 billion, a PE ratio of 16.57 and a beta of 0.80. The firm’s 50-day moving average is $75.30 and its 200-day moving average is $76.84.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Wednesday, August 2nd. The company reported $1.31 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.24 by $0.07. The business had revenue of $32.97 billion during the quarter, compared to the consensus estimate of $32.73 billion. Cardinal Health had a return on equity of 26.20% and a net margin of 0.99%. The business’s revenue was up 5.0% on a year-over-year basis. During the same period in the previous year, the firm posted $1.14 earnings per share. On average, analysts predict that Cardinal Health, Inc. will post $4.97 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Sunday, October 15th. Stockholders of record on Monday, October 2nd will be given a dividend of $0.4624 per share. The ex-dividend date of this dividend is Friday, September 29th. This represents a $1.85 annualized dividend and a dividend yield of 2.77%. Cardinal Health’s dividend payout ratio is presently 45.79%.

A number of large investors have recently made changes to their positions in CAH. Vanguard Group Inc. boosted its stake in shares of Cardinal Health by 1.9% in the second quarter. Vanguard Group Inc. now owns 23,642,277 shares of the company’s stock valued at $1,842,205,000 after buying an additional 440,967 shares during the last quarter. BlackRock Inc. boosted its stake in shares of Cardinal Health by 6.5% in the second quarter. BlackRock Inc. now owns 22,843,418 shares of the company’s stock valued at $1,779,958,000 after buying an additional 1,398,496 shares during the last quarter. State Street Corp boosted its stake in shares of Cardinal Health by 1.1% in the first quarter. State Street Corp now owns 16,790,201 shares of the company’s stock valued at $1,369,247,000 after buying an additional 176,331 shares during the last quarter. Franklin Resources Inc. boosted its stake in shares of Cardinal Health by 72.1% in the second quarter. Franklin Resources Inc. now owns 6,283,529 shares of the company’s stock valued at $489,613,000 after buying an additional 2,632,836 shares during the last quarter. Finally, FMR LLC boosted its stake in shares of Cardinal Health by 47.1% in the first quarter. FMR LLC now owns 5,915,289 shares of the company’s stock valued at $482,391,000 after buying an additional 1,895,089 shares during the last quarter. 86.41% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: This article was first posted by Watch List News and is the property of of Watch List News. If you are reading this article on another publication, it was copied illegally and reposted in violation of US and international copyright laws. The original version of this article can be read at https://www.watchlistnews.com/investors-buy-shares-of-cardinal-health-inc-nysecah-on-weakness/1487951.html.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.